WINNER OF THE GUARDIAN FIRST BOOK AWARD 2011 WINNER OF THE PULITZER PRIZE FOR NON-FICTION 2011 ‘Profound, eloquent and searching’ SUNDAY TIMES ‘Essential reading’ INDEPENDENT ‘Masterly’ GUARDIAN ‘Extraordinary’ NEW YORK TIMES BOOK REVIEW AN OBSERVER BEST BOOK OF THE CENTURY SO FAR Riveting, audacious and now more urgent than ever in this vast update, The Emperor of All Maladies is a masterpiece. The story of cancer is a human one – a tale of chance discoveries, seized opportunities and human endurance. From innovative early surgeries to the Curies’ ultimately tragic work with radiation; from Sidney Farber’s hugely risky discovery of chemotherapy to the author’s treatment of his own patients, The Emperor of All Maladies is a profound and revelatory portrait of an enigmatic disease humans have lived with, and perished from, for more than five thousand years. In this updated edition of Siddhartha Mukherjee’s instant classic, four new chapters reveal what has changed in the universe of cancer in the years since the book was first published. With moving eloquence, he offers an insight into our evolving understanding of cancer’s causes and the emerging, revolutionary new treatments that might shape its future, including those that Mukherjee himself has helped devise. ‘This elegantly written overview allows us to look a once whispered-about illness squarely in the eye’ INDEPENDENT ‘The notion of “popular science” doesn’t come close to describing this achievement. It is literature’ OBSERVER
The Emperor of All Maladies : A Biography of Cancer – 9780008811105
R361,00 Original price was: R361,00.R325,00Current price is: R325,00.
Published in United Kingdom…..UK import usually dispatched in 14 to 20 working days
SKU: 9780008811105
Category: technology & engineering
Tags: 9780008811105, The Emperor of All Maladies : A Biography of Cancer
Be the first to review “The Emperor of All Maladies : A Biography of Cancer – 9780008811105” Cancel reply
Related products
-9%
-9%
-10%
-10%
-10%
-9%
-10%
-9%




Reviews
There are no reviews yet.